Dr Reddy’s acquires Wockhardt’s India business for Rs 1,850 cr
Dr Reddy’s Laboratories (DRL) has entered into an agreement with Wockhardt to acquire a majority of Wockhardt’s domestic formulations business […]
Say something
Dr Reddy’s Laboratories (DRL) has entered into an agreement with Wockhardt to acquire a majority of Wockhardt’s domestic formulations business […]
Dr Reddy’s Laboratories has recalled all its ranitidine medications sold in the US after certain samples of it were found […]
Cipla, Dr Reddy’s, and Lupin, are among pharma companies which got notice for launching drugs in the market without taking […]
Dr Reddy’s Laboratories has acquired a portfolio of 42 abbreviated new drug applications (ANDAs) in the US. Based in Hyderabad, […]